NEW ORLEANS--(BUSINESS WIRE)--St Charles Pharmaceuticals, Inc. (www.stcharlespharma.com), a Louisiana-headquartered pharmaceutical company developing novel, more universally effective therapeutics for pain relief, announced today that it has received funding for the first year of a 3-year $3.1 million special National Institute of Neurological Disorders and Stroke (NINDS) Small Business Innovative Research (SBIR) Grant.
